TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 17
1.2 MARKET ATTRACTIVENESS ANALYSIS 18
1.2.1 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE 18
1.2.1.1 GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES 19
1.2.2 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY 20
1.2.3 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES 21
1.2.4 GLOBAL EPILEPSY DEVICES MARKET, BY END USE 22
1.2.5 GLOBAL EPILEPSY DEVICES MARKET, BY REGION 23
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 24
2.2 RESEARCH OBJECTIVE 24
2.3 MARKET STRUCTURE 25
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS 26
3.2 PRIMARY RESEARCH 27
3.3 SECONDARY RESEARCH 28
3.4 MARKET SIZE ESTIMATION 28
3.5 FORECAST MODEL 30
3.6 LIST OF ASSUMPTIONS & LIMITATIONS 31
4 MARKET DYNAMICS
4.1 INTRODUCTION 32
4.2 DRIVERS 33
4.2.1 RISING PREVALENCE OF EPILEPSY AMONGST THE GERIATRIC POPULATION 33
4.2.2 INCREASING CASES OF BRAIN INJURIES DUE TO ROAD ACCIDENTS 33
4.2.3 RISING NEUROLOGICAL DISORDERS 33
4.2.4 INCREASING RESEARCH FUNDING IN EPILEPSY 34
4.2.5 DRIVERS IMPACT ANALYSIS 34
4.3 RESTRAINTS 35
4.3.1 LOSS OF PATENT PROTECTION FOR BRANDED DRUGS 35
4.3.2 HIGH COSTS ASSOCIATED WITH THE TREATMENT OF EPILEPSY 35
4.3.3 RESTRAINTS IMPACT ANALYSIS 35
4.4 OPPORTUNITIES 36
4.4.1 ENTERING DEVELOPING ECONOMIES 36
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN 37
5.1.1 RESEARCH & DEVELOPMENT AND DESIGNING 37
5.1.2 MANUFACTURING 37
5.1.3 DISTRIBUTION & SALES 37
5.1.4 POST-SALES SERVICES 38
5.2 PORTER’S FIVE FORCES MODEL 38
5.2.1 THREAT OF NEW ENTRANTS 38
5.2.2 BARGAINING POWER OF SUPPLIERS 39
5.2.3 THREAT OF SUBSTITUTES 39
5.2.4 BARGAINING POWER OF BUYERS 39
5.2.5 INTENSITY OF RIVALRY 39
5.3 IMPACT OF COVID-19 ON THE GLOBAL EPILEPSY DEVICES MARKET 39
5.3.1 OVERVIEW 39
5.3.2 IMPACT ON SUPPLY CHAIN 40
5.3.3 IMPACT ON PRODUCTION/MANUFACTURERS 40
5.3.4 IMPACT ON REGIONS 40
5.3.5 IMPACT ON DEMAND 40
6 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE
6.1 INTRODUCTION 41
6.2 WEARABLE DEVICES 42
6.2.1 WATCHES 43
6.2.2 BRACELETS 43
6.2.3 CAMERA DEVICES 43
6.2.4 MATTRESS DEVICES 44
6.2.5 ANTI-SUFFOCATION PILLOWS 44
6.2.6 OTHERS 44
6.3 CONVENTIONAL DEVICES 45
6.4 IMPLANTABLE DEVICES 45
7 GLOBAL EPILEPSY DEVICES MARKET BY TECHNOLOGY
7.1 OVERVIEW 46
7.2 VAGUS NERVE STIMULATION (VNS) 47
7.3 RESPONSIVE NEUROSTIMULATION 47
7.4 DEEP BRAIN STIMULATION 48
7.5 ACCELEROMETRY 48
8 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND
PREDICTION DEVICES
8.1 OVERVIEW 49
8.2 ELECTROENCEPHALOGRAM (EEG) 50
8.3 INTRACRANIAL EEG 51
8.4 SURFACE ELECTROMYOGRAPHY (SEMG) 51
8.5 ELECTRODERMAL ACTIVITY (EDA) 51
8.6 ELECTROCARDIOGRAPHY (EKG) 52
8.7 VIDEO DETECTION SYSTEMS 52
8.8 IMPLANTED ADVISORY SYSTEMS 53
8.9 OTHERS 53
9 GLOBAL EPILEPSY DEVICES MARKET, BY END USE
9.1 OVERVIEW 54
9.2 HOSPITALS & CLINICS 55
9.3 NEUROLOGY CENTERS 55
9.4 HOME CARE SETTINGS 56
9.5 OTHERS 56
10 GLOBAL EPILEPSY DEVICES MARKET, BY REGION
10.1 INTRODUCTION 57
10.2 AMERICAS 58
10.2.1 NORTH AMERICA 61
10.2.1.1 US 64
10.2.1.2 CANADA 66
10.2.2 LATIN AMERICA 68
10.3 EUROPE 70
10.3.1 WESTERN EUROPE 73
10.3.1.1 GERMANY 76
10.3.1.2 FRANCE 78
10.3.1.3 UK 80
10.3.1.4 ITALY 82
10.3.1.5 SPAIN 84
10.3.1.6 REST OF WESTERN EUROPE 86
10.3.2 EASTERN EUROPE 88
10.4 ASIA-PACIFIC 90
10.4.1 CHINA 93
10.4.2 INDIA 95
10.4.3 JAPAN 97
10.4.4 AUSTRALIA 99
10.4.5 SOUTH KOREA 101
10.4.6 REST OF ASIA-PACIFIC 103
10.5 MIDDLE EAST & AFRICA 105
10.5.1 MIDDLE EAST 108
10.5.2 AFRICA 110
11 COMPETITIVE LANDSCAPE
11.1 COMPETITIVE OVERVIEW 112
11.2 COMPETITOR DASHBOARD 112
11.3 MARKET SHARE ANALYSIS 113
11.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL EPILEPSY DEVICES MARKET 114
11.5 COMPETITIVE BENCHMARKING 115
11.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL EPILEPSY DEVICES MARKET 116
11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 117
11.7.1 PRODUCT DEVELOPMENTS/LAUNCHES 117
11.7.2 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES 118
11.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 118
11.8.1 SALES & OPERATING INCOME 118
11.8.2 R&D EXPENDITURE 119
12 COMPANY PROFILES
12.1 BOSTON SCIENTIFIC CORPORATION 120
12.1.1 COMPANY OVERVIEW 120
12.1.2 FINANCIAL OVERVIEW 121
12.1.3 PRODUCTS/SERVICES OFFERED 122
12.1.4 KEY DEVELOPMENTS 122
12.1.5 SWOT ANALYSIS 123
12.1.6 KEY STRATEGIES 123
12.2 MEDPAGE LTD. (EASYLINK UK) 124
12.2.1 COMPANY OVERVIEW 124
12.2.2 FINANCIAL OVERVIEW 124
12.2.3 PRODUCTS/SERVICES OFFERED 124
12.2.4 KEY DEVELOPMENTS 125
12.2.5 SWOT ANALYSIS 125
12.2.6 KEY STRATEGIES 125
12.3 CERBOMED GMBH (TVNS TECHNOLOGIES GMBH) 126
12.3.1 COMPANY OVERVIEW 126
12.3.2 FINANCIAL OVERVIEW 126
12.3.3 PRODUCTS/SERVICES OFFERED 126
12.3.4 KEY DEVELOPMENTS 126
12.3.5 SWOT ANALYSIS 127
12.3.6 KEY STRATEGIES 127
12.4 LIVA NOVA (CYBERONICS) 128
12.4.1 COMPANY OVERVIEW 128
12.4.2 FINANCIAL OVERVIEW 129
12.4.3 PRODUCTS/SERVICES OFFERED 129
12.4.4 KEY DEVELOPMENTS 130
12.4.5 SWOT ANALYSIS 130
12.4.6 KEY STRATEGIES 130
12.5 COMPUMEDICS 131
12.5.1 COMPANY OVERVIEW 131
12.5.2 FINANCIAL OVERVIEW 131
12.5.3 PRODUCTS/SERVICES OFFERED 132
12.5.4 KEY DEVELOPMENTS 132
12.5.5 SWOT ANALYSIS 133
12.5.6 KEY STRATEGIES 133
12.6 NIHON KOHDEN 134
12.6.1 COMPANY OVERVIEW 134
12.6.2 FINANCIAL OVERVIEW 135
12.6.3 PRODUCTS/SERVICES OFFERED 136
12.6.4 KEY DEVELOPMENTS 136
12.6.5 SWOT ANALYSIS 137
12.6.6 KEY STRATEGIES 137
12.7 MC10 138
12.7.1 COMPANY OVERVIEW 138
12.7.2 FINANCIAL OVERVIEW 138
12.7.3 PRODUCTS/SERVICES OFFERED 138
12.7.4 KEY DEVELOPMENTS 138
12.7.5 SWOT ANALYSIS 139
12.7.6 KEY STRATEGIES 139
12.8 EMPATICA, INC. 140
12.8.1 COMPANY OVERVIEW 140
12.8.2 FINANCIAL OVERVIEW 140
12.8.3 PRODUCTS/SERVICES OFFERED 140
12.8.4 KEY DEVELOPMENTS 140
12.8.5 SWOT ANALYSIS 141
12.8.6 KEY STRATEGIES 141
12.9 MEDTRONIC PLC 142
12.9.1 COMPANY OVERVIEW 142
12.9.2 FINANCIAL OVERVIEW 143
12.9.3 PRODUCTS/SERVICES OFFERED 143
12.9.4 KEY DEVELOPMENTS 144
12.9.5 SWOT ANALYSIS 144
12.9.6 KEY STRATEGIES 144
12.10 NEUROPACE, INC. 145
12.10.1 COMPANY OVERVIEW 145
12.10.2 FINANCIAL OVERVIEW 145
12.10.3 PRODUCTS/SERVICES OFFERED 145
12.10.4 KEY DEVELOPMENTS 145
12.10.5 SWOT ANALYSIS 146
12.10.6 KEY STRATEGIES 146
12.11 NATUS MEDICAL INCORPORATED 147
12.11.1 COMPANY OVERVIEW 147
12.11.2 FINANCIAL OVERVIEW 148
12.11.3 PRODUCTS/SERVICES OFFERED 149
12.11.4 KEY DEVELOPMENTS 149
12.11.5 SWOT ANALYSIS 150
12.11.6 KEY STRATEGIES 150
13 APPENDIX
13.1 REFERENCES 151″
LIST OF TABLESTABLE 1 PRIMARY INTERVIEWS 27
TABLE 2 LIST OF ASSUMPTIONS & LIMITATIONS 31
TABLE 3 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 41
TABLE 4 GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY REGION, 2020–2027 (USD MILLION) 42
TABLE 5 GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 42
TABLE 6 GLOBAL EPILEPSY DEVICES MARKET, BY WATCHES, BY REGION, 2020–2027 (USD MILLION) 43
TABLE 7 GLOBAL EPILEPSY DEVICES MARKET, BY BRACELETS, BY REGION, 2020–2027 (USD MILLION) 43
TABLE 8 GLOBAL EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, BY REGION, 2020–2027 (USD MILLION) 43
TABLE 9 GLOBAL EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, BY REGION, 2020–2027 (USD MILLION) 44
TABLE 10 GLOBAL EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, BY REGION, 2020–2027 (USD MILLION) 44
TABLE 11 GLOBAL EPILEPSY DEVICES MARKET, BY OTHERS, BY REGION, 2020–2027 (USD MILLION) 44
TABLE 12 GLOBAL EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, BY REGION, 2020–2027 (USD MILLION) 45
TABLE 13 GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, BY REGION, 2020–2027 (USD MILLION) 45
TABLE 14 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 46
TABLE 15 GLOBAL EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION (VNS), BY REGION, 2020–2027 (USD MILLION) 47
TABLE 16 GLOBAL EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, BY REGION, 2020–2027 (USD MILLION) 47
TABLE 17 GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, BY REGION, 2020–2027 (USD MILLION) 48
TABLE 18 GLOBAL EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, BY REGION, 2020–2027 (USD MILLION) 48
TABLE 19 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 49
TABLE 20 GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM (EEG), BY REGION, 2020–2027 (USD MILLION) 50
TABLE 21 GLOBAL EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, BY REGION, 2020–2027 (USD MILLION) 51
TABLE 22 GLOBAL EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY (SEMG), BY REGION, 2020–2027 (USD MILLION) 51
TABLE 23 GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM (EEG), BY REGION, 2020–2027 (USD MILLION) 51
TABLE 24 GLOBAL EPILEPSY DEVICES MARKET BY ELECTROCARDIOGRAPHY (EKG), BY REGION, 2020–2027 (USD MILLION) 52
TABLE 25 GLOBAL EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 52
TABLE 26 GLOBAL EPILEPSY DEVICES MARKET BY IMPLANTED ADVISORY SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 53
TABLE 27 GLOBAL EPILEPSY DEVICES MARKET, BY OTHERS, BY REGION, 2020–2027 (USD MILLION) 53
TABLE 28 GLOBAL EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 54
TABLE 29 GLOBAL EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 55
TABLE 30 GLOBAL EPILEPSY DEVICES MARKET BY NEUROLOGY CENTERS, BY REGION, 2020–2027 (USD MILLION) 55
TABLE 31 GLOBAL EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION) 56
TABLE 32 GLOBAL EPILEPSY DEVICES MARKET, BY OTHERS, BY REGION, 2020–2027 (USD MILLION) 56
TABLE 33 GLOBAL EPILEPSY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 57
TABLE 34 AMERICAS: EPILEPSY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 58
TABLE 35 AMERICAS: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 58
TABLE 36 AMERICAS: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 59
TABLE 37 AMERICAS: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 59
TABLE 38 AMERICAS: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 60
TABLE 39 AMERICAS: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 60
TABLE 40 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 61
TABLE 41 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 61
TABLE 42 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 62
TABLE 43 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 62
TABLE 44 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,
2020–2027 (USD MILLION) 63
TABLE 45 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 63
TABLE 46 US: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 64
TABLE 47 US: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 64
TABLE 48 US: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 64
TABLE 49 US: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 65
TABLE 50 US: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 65
TABLE 51 CANADA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 66
TABLE 52 CANADA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 66
TABLE 53 CANADA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 66
TABLE 54 CANADA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 67
TABLE 55 CANADA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 67
TABLE 56 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 68
TABLE 57 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 68
TABLE 58 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 68
TABLE 59 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 69
TABLE 60 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 69
TABLE 61 EUROPE: EPILEPSY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 70
TABLE 62 EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 70
TABLE 63 EUROPE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 64 EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71
TABLE 65 EUROPE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 72
TABLE 66 EUROPE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 72
TABLE 67 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73
TABLE 68 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 73
TABLE 69 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 70 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 74
TABLE 71 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,
2020–2027 (USD MILLION) 75
TABLE 72 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 75
TABLE 73 GERMANY: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 76
TABLE 74 GERMANY: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 75 GERMANY: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 76
TABLE 76 GERMANY: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 77
TABLE 77 GERMANY: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 77
TABLE 78 FRANCE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 78
TABLE 79 FRANCE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 78
TABLE 80 FRANCE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 78
TABLE 81 FRANCE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 79
TABLE 82 FRANCE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 79
TABLE 83 UK: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 80
TABLE 84 UK: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 85 UK: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 80
TABLE 86 UK: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 81
TABLE 87 UK: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 81
TABLE 88 ITALY: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 82
TABLE 89 ITALY: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 82
TABLE 90 ITALY: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 82
TABLE 91 ITALY: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 83
TABLE 92 ITALY: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 83
TABLE 93 SPAIN: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 84
TABLE 94 SPAIN: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 95 SPAIN: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 84
TABLE 96 SPAIN: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 85
TABLE 97 SPAIN: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 85
TABLE 98 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 86
TABLE 99 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 100 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86
TABLE 101 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,
2020–2027 (USD MILLION) 87
TABLE 102 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 87
TABLE 103 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 88
TABLE 104 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 105 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88
TABLE 106 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,
2020–2027 (USD MILLION) 89
TABLE 107 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 89
TABLE 108 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 109 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 90
TABLE 110 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 111 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 91
TABLE 112 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 92
TABLE 113 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 92
TABLE 114 CHINA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 93
TABLE 115 CHINA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 116 CHINA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 93
TABLE 117 CHINA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 94
TABLE 118 CHINA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 94
TABLE 119 INDIA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 95
TABLE 120 INDIA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 121 INDIA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 95
TABLE 122 INDIA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 96
TABLE 123 INDIA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 96
TABLE 124 JAPAN: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 97
TABLE 125 JAPAN: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 126 JAPAN: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 97
TABLE 127 JAPAN: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 98
TABLE 128 JAPAN: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 98
TABLE 129 AUSTRALIA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 99
TABLE 130 AUSTRALIA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 131 AUSTRALIA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 99
TABLE 132 AUSTRALIA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 100
TABLE 133 AUSTRALIA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 100
TABLE 134 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 101
TABLE 135 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 136 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 101
TABLE 137 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 102
TABLE 138 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 102
TABLE 139 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 103
TABLE 140 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 141 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 103
TABLE 142 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,
2020–2027 (USD MILLION) 104
TABLE 143 REST OF ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 104
TABLE 144 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 105
TABLE 145 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 105
TABLE 146 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 147 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 106
TABLE 148 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES,
2020–2027 (USD MILLION) 107
TABLE 149 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 107
TABLE 150 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 108
TABLE 151 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 152 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 108
TABLE 153 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 109
TABLE 154 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 109
TABLE 155 AFRICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 110
TABLE 156 AFRICA: EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 157 AFRICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 110
TABLE 158 AFRICA: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020–2027 (USD MILLION) 111
TABLE 159 AFRICA: EPILEPSY DEVICES MARKET, BY END USE, 2020–2027 (USD MILLION) 111
TABLE 160 COMPETITOR DASHBOARD: GLOBAL EPILEPSY DEVICES MARKET 112
TABLE 161 THE MOST ACTIVE PLAYERS IN THE GLOBAL EPILEPSY DEVICES MARKET 116
TABLE 162 PRODUCT DEVELOPMENTS/LAUNCHES 117
TABLE 163 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/JOINT VENTURES 118
TABLE 164 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED 122
TABLE 165 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS 122
TABLE 166 MEDPAGE LTD: PRODUCTS/SERVICES OFFERED 124
TABLE 167 CEREBOMED GMBH: PRODUCTS/SERVICES OFFERED 126
TABLE 168 LIVANOVA: PRODUCTS/SERVICES OFFERED 129
TABLE 169 COMPUMEIDCS: PRODUCTS/SERVICES OFFERED 132
TABLE 170 NIHON KOHDEN: PRODUCTS/SERVICES OFFERED 136
TABLE 171 NIHON KOHDEN: KEY DEVELOPMENTS 136
TABLE 172 MC10: PRODUCTS/SERVICES OFFERED 138
TABLE 173 EMPATICA, INC.: PRODUCTS/SERVICES OFFERED 140
TABLE 174 EMPATICA, INC.: KEY DEVELOPMENTS 140
TABLE 175 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED 143
TABLE 176 MEDTRONIC PLC: KEY DEVELOPMENTS 144
TABLE 177 NEUROPACE, INC: PRODUCTS/SERVICES OFFERED 145
TABLE 178 NEUROPACE, INC: KEY DEVELOPMENTS 145
TABLE 179 NATUS MEDICAL INCORPORATED: PRODUCTS/SERVICES OFFERED 149
TABLE 180 NATUS MEDICAL INCORPORATED: KEY DEVELOPMENTS 149
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 17
FIGURE 2 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE 18
FIGURE 3 GLOBAL EPILEPSY DEVICES MARKET, BY ELECTRIC WEARABLE DEVICES 19
FIGURE 4 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY 20
FIGURE 5 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES 21
FIGURE 6 GLOBAL EPILEPSY DEVICES MARKET, BY END USE 22
FIGURE 7 GLOBAL EPILEPSY DEVICES MARKET ANALYSIS, BY REGION 23
FIGURE 8 GLOBAL EPILEPSY DEVICES MARKET: STRUCTURE 25
FIGURE 9 RESEARCH PROCESS 26
FIGURE 10 TOP-DOWN AND BOTTOM-UP APPROACHES 29
FIGURE 11 MARKET DYNAMICS OVERVIEW: EPILEPSY DEVICES MARKET 32
FIGURE 12 DRIVERS IMPACT ANALYSIS: GLOBAL EPILEPSY DEVICES MARKET 34
FIGURE 13 RESTRAINTS IMPACT ANALYSIS: GLOBAL EPILEPSY DEVICES MARKET 35
FIGURE 14 GLOBAL EPILEPSY DEVICES MARKET: VALUE CHAIN 37
FIGURE 15 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL EPILEPSY DEVICES MARKET 38
FIGURE 16 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 41
FIGURE 17 GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, BY TYPE, 2020 & 2027 (USD MILLION) 42
FIGURE 18 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION) 46
FIGURE 19 GLOBAL EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020 & 2027 (USD MILLION) 50
FIGURE 20 GLOBAL EPILEPSY DEVICES MARKET, BY END USE, 2020 & 2027 (USD MILLION) 55
FIGURE 21 GLOBAL EPILEPSY DEVICES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 57
FIGURE 22 AMERICAS: EPILEPSY DEVICES MARKET SHARE, BY REGION 2020 (%) 58
FIGURE 23 NORTH AMERICA: EPILEPSY DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 61
FIGURE 24 EUROPE: EPILEPSY DEVICES MARKET SHARE, BY REGION 2020 (%) 70
FIGURE 25 WESTERN EUROPE: EPILEPSY DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 73
FIGURE 26 ASIA-PACIFIC: EPILEPSY DEVICES MARKET SHARE, BY COUNTRY 2020 (%) 90
FIGURE 27 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET SHARE, BY REGION 2020 (%) 105
FIGURE 28 MAJOR MANUFACTURERS MARKET SHARE ANALYSIS, 2020 113
FIGURE 29 CONTRACTS & AGREEMENTS: THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL
EPILEPSY DEVICES MARKET 114
FIGURE 30 BENCHMARKING OF MAJOR COMPETITORS 115
FIGURE 31 SALES & OPERATING INCOME 2020 118
FIGURE 32 MAJOR PLAYERS R&D EXPENDITURE 2020 119
FIGURE 33 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 121
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 123
FIGURE 35 MEDPAGE LTD.: SWOT ANALYSIS 125
FIGURE 36 CEREBOMED GMBH: SWOT ANALYSIS 127
FIGURE 37 LIVANOVA: FINANCIAL OVERVIEW SNAPSHOT 129
FIGURE 38 LIVANOVA: SWOT ANALYSIS 130
FIGURE 39 COMPUMEDICS: FINANCIAL OVERVIEW SNAPSHOT 131
FIGURE 40 COMPUMEDICS: SWOT ANALYSIS 133
FIGURE 41 NIHON KOHDEN: PRODUCTS/SERVICES OFFERED 135
FIGURE 42 NIHON KOHDEN: SWOT ANALYSIS 137
FIGURE 43 MC10: SWOT ANALYSIS 139
FIGURE 44 EMPATICA, INC.: SWOT ANALYSIS 141
FIGURE 45 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 143
FIGURE 46 MEDTRONIC PLC: SWOT ANALYSIS 144
FIGURE 47 NEUROPACE, INC: SWOT ANALYSIS 146
FIGURE 48 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT 148
FIGURE 49 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS 150